GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Inc (ROCO:6892) » Definitions » Long-Term Debt

Taiwan Bio Therapeutics (ROCO:6892) Long-Term Debt : NT$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics Long-Term Debt?

Taiwan Bio Therapeutics's Long-Term Debt for the quarter that ended in Dec. 2024 was NT$0.00 Mil.

Taiwan Bio Therapeutics Long-Term Debt Historical Data

The historical data trend for Taiwan Bio Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics Long-Term Debt Chart

Taiwan Bio Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
Get a 7-Day Free Trial - - - - -

Taiwan Bio Therapeutics Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Taiwan Bio Therapeutics  (ROCO:6892) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Taiwan Bio Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Bio Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Inc (ROCO:6892) » Definitions » Long-Term Debt
Comparable Companies
ROCO:6580 ROCO:6461 ROCO:6492 ROCO:6748 ROCO:6676 ROCO:4130 ROCO:7808 TPE:1762 ROCO:1295 TPE:6885 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Tiding Avenue, 5th Floor, No. 501, Section 2, Neihu District, Zhubei, TWN, 114744
Website
https://www.twbio-thera.com
Taiwan Bio Therapeutics Inc is a regenerative medicine company specializing in the development of new genetically modified cell drugs. It is providing commissioned development and manufacturing (CDMO/CMO) services and inspection, analysis and development services for cellular medical products.

Taiwan Bio Therapeutics Headlines

No Headlines